Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia - Galluppi, Gerald R.; Polhamus, Daniel G.; Fisher, Jeannine M.; Hopkins, Seth C.; Koblan, Kenneth S. (CPT: pharmacometrics and systems pharmacology, 2021)
Keywords: Adolescent; Adult; Asian people; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dopamine; Drug dosages; Female; GLP-1 receptor agonists; Healthy Volunteers; Humans; Male; Mental disorders; Middle Aged; Patients; Pharmacokinetics; Plasma; Population; Psychotropic drugs; Pyrans - pharmacokinetics; Pyrans - therapeutic use; Receptor, Serotonin, 5-HT1A; Receptors, G-Protein-Coupled - agonists; Schizophrenia; Schizophrenia - drug therapy; Serotonin 5-HT1 Receptor Agonists - pharmacokinetics; Serotonin 5-HT1 Receptor Agonists - therapeutic use; Young Adult; United States--US